Get the Stockscreener App
6.63
2.63%
0.17
After Hours:
6.60
-0.03
-0.45%
Teladoc Health Inc stock is traded at $6.63, with a volume of 6.70M.
It is up +2.63% in the last 24 hours and up +25.81% over the past month.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
See More
Previous Close:
$6.46
Open:
$6.49
24h Volume:
6.70M
Relative Volume:
1.14
Market Cap:
$1.20B
Revenue:
$2.51B
Net Income/Loss:
$-171.15M
P/E Ratio:
-6.8826
EPS:
-0.9633
Net Cash Flow:
$122.59M
1W Performance:
+13.33%
1M Performance:
+25.81%
6M Performance:
-16.92%
1Y Performance:
-6.09%
1-Day Range:
$6.33
$6.665
1-Week Range:
$5.23
$6.755
52-Week Range:
$4.40
$9.77
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.63 | 1.17B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
170.22 | 28.03B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
53.54 | 10.16B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
55.81 | 9.87B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.18 | 6.96B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
24.89 | 4.61B | 637.78M | 239.40M | 307.21M | 1.1909 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-26-26 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
TDOC Q1 Earnings Miss, Revenues Down Y/Y on BetterHelp Weakness - TradingView
Is It Time To Reconsider Teladoc Health (TDOC) After The Recent Share Price Rebound? - Sahm
Teladoc Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:TDOC) 2026-05-03 - Seeking Alpha
Teladoc Q1 preview: Profits seen improving, BetterHelp operations in focus - MSN
Why Is Teladoc (TDOC) Stock Soaring Today - Yahoo Finance
Are These Beaten-Down Stocks Generational Opportunities or Value Traps? - AOL.com
Earnings snapshot: Teladoc Health issues weak Q2 revenue outlook after mixed Q1 results - MSN
Teladoc Health Q1 2026 Results: Revenue Beat, Sales Drop, and AI-Driven Forward GuidanceNews and Statistics - IndexBox
Teladoc Health Q1 Earnings Call Highlights - Yahoo Finance
TDOC Q1 Deep Dive: AI-Enabled Product Rollout and Insurance Expansion Drive Strategic Shifts - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Teladoc Health (NYSE:TDOC) Stock Price Up 7.7%Here's Why - MarketBeat
TDOC SEC FilingsTeladoc Health Inc 10-K, 10-Q, 8-K Forms - Stock Titan
UHS, Acadia, Teladoc Plot Course for 2026 - Behavioral Health Business
Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC) - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Teladoc (TDOC), Pfizer (PFE) - The Globe and Mail
Teladoc Q4 earnings: Can integrated care strength save profits? - MSN
Teladoc Health Exceeds Revenue Guidance Driven by Integrated Care - HarianBasis.co
Jefferies raises Teladoc stock price target to $6 on Q1 results - Investing.com
TDOC Stock Price, Quote & Chart | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
TDOC SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Teladoc Earnings Call: Insurance Momentum Amid Headwinds - TipRanks
Investment Opportunities in Teladoc and PayPal - Intellectia AI
Teladoc Health Q1 2026 revenue down 2% to USD 613.8M - Medical Buyer
Vanguard reports 9.21M Teladoc shares (TDOC) as 5.16% stake - Stock Titan
Truist Financial Maintains Teladoc Health(TDOC.US) With Hold Rating - Moomoo
HIMS vs. TDOC: Which Digital Health Stock Offers Better Upside Now? - Yahoo Finance
Evercore Maintains Teladoc Health(TDOC.US) With Hold Rating, Maintains Target Price $6 - Moomoo
Teladoc (TDOC) Q1 2026 Earnings Transcript - AOL.com
Teladoc Health (NYSE:TDOC) Shares Gap Down on Disappointing Earnings - MarketBeat
How Teladoc’s Narrower Q1 Loss Amid Softer Revenue At Teladoc Health (TDOC) Has Changed Its Investment Story - Yahoo Finance
Teladoc Health (TDOC) narrows Q1 2026 loss as Integrated Care grows - Stock Titan
Teladoc Stock Slides Following Q1 Earnings Miss, Lower Guidance - Benzinga
A Quick Look at Today's Ratings for Teladoc Health(TDOC.US), With a Forecast Between $6 to $10 - Moomoo
Teladoc Health, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
BofA raises Teladoc stock price target on insurance transition By Investing.com - Investing.com Canada
Retailers shift healthcare strategy to GLP-1s after clinic setbacks - Modern Healthcare
Teladoc Health (TDOC) Reports Strong Q1 2026 Earnings Performanc - GuruFocus
Barclays Maintains Teladoc Health(TDOC.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Teladoc Health Q1 2026 Earnings Call Transcript - MarketBeat
Earnings Call Summary | Teladoc Health(TDOC.US) Q1 2026 Earnings Conference - Moomoo
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Responsive Playbooks and the TDOC Inflection - Stock Traders Daily
How Teladoc’s Slower Revenue but Narrower Losses Will Impact Teladoc Health (TDOC) Investors - simplywall.st
Teladoc Health (TDOC) Reports Q1 Earnings Miss, Stock Drops 5% i - GuruFocus
Teladoc Health (NYSE:TDOC) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
TDOC Projects Q2 Revenue Between $597M and $626M - GuruFocus
Teladoc falls following Q1 EPS miss; 2026 guidance ranges include consensus - MSN
Earnings call transcript: Teladoc Q1 2026 revenue beats forecasts, stock sees modest gain - Investing.com
Here's What Key Metrics Tell Us About Teladoc (TDOC) Q1 Earnings - Yahoo Finance
Teladoc Health (TDOC) Q1 2026: EPS -$0.36 (Miss vs -$0.33 Est.), - GuruFocus
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.48%
7.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):